Board Meeting5 Aug 2026, 07:00 pm
Vaxfab Enterprises Board Meeting on Aug 14 to Approve Q1 FY27 Results
AI Summary
Vaxfab Enterprises Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. Concurrently, the company has confirmed that the trading window for its designated persons, which commenced on July 1, 2026, will remain closed until 48 hours after the submission of these financial results. This ensures compliance with insider trading regulations during the sensitive period leading up to and immediately following the results announcement.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- Agenda includes approval of unaudited Q1 FY27 financial results.
- Trading window closure extended until 48 hours post-results submission.
- Ensures compliance with regulatory requirements for financial reporting.
Price Impact
More from VEL